Variable | Control (n=203) | ACS (n=252) | SA (n=112) |
ApoB100 IgG | 1.99±0.05 | 1.76±0.04* | 1.7±0.07* |
ApoB100 IgM | 0.81±0.04 | 0.68±0.03* | 0.71±0.05 |
HSP60 IgG | 2.23±0.05 | 2.05±0.05* | 2.03±0.07 |
HSP60 IgM | 0.92±0.04 | 0.8±0.04* | 0.8±0.05 |
ApoB100 IgG (peptide) | 1.45±0.05 | 1.35±0.05 | 1.42±0.09 |
HSP60 IgG (peptide) | 2.21±0.09 | 1.94±0.08* | 2.0±0.19 |
Antibody levels were measured by ELISA. Absorbance values at a dilution of 1:100 are compared between control and patient group using multivariate analysis by taking age, gender, body mass index (BMI), current smoking, hypertension and diabetes as covariates.
P value <0.05 was considered as significant. *P<0.05.
ACS, acute coronary syndrome; ApoB, apolipoprotein B; HSP, heat shock protein; SA, stable angina.